Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 29, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

October 31, 2026

Conditions

End Stage Renal Disease on DialysisPeritoneal Dialysis ComplicationSodium-glucose Cotransporter-2 InhibitorResidual Kidney Function

Interventions

DRUG

Empagliflozin 10 MG

empagliflozin oral 10mg daily for 6 months

Trial Locations (1)

RECRUITING

Chinese University of Hong Kong, Hong Kong

All Listed Sponsors

lead

Chinese University of Hong Kong

OTHER